Cargando…
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
Clinical successes demonstrated by chimeric antigen receptor T-cell immunotherapy have facilitated further development of T-cell immunotherapy against wide variety of diseases. One approach is the development of “off-the-shelf” T-cell sources. Technologies to generate T-cells from pluripotent stem c...
Autores principales: | Iriguchi, Shoichi, Yasui, Yutaka, Kawai, Yohei, Arima, Suguru, Kunitomo, Mihoko, Sato, Takayuki, Ueda, Tatsuki, Minagawa, Atsutaka, Mishima, Yuta, Yanagawa, Nariaki, Baba, Yuji, Miyake, Yasuyuki, Nakayama, Kazuhide, Takiguchi, Maiko, Shinohara, Tokuyuki, Nakatsura, Tetsuya, Yasukawa, Masaki, Kassai, Yoshiaki, Hayashi, Akira, Kaneko, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814014/ https://www.ncbi.nlm.nih.gov/pubmed/33462228 http://dx.doi.org/10.1038/s41467-020-20658-3 |
Ejemplares similares
-
Toward the development of true “off‐the‐shelf” synthetic T‐cell immunotherapy
por: Iriguchi, Shoichi, et al.
Publicado: (2019) -
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
por: Ito, Takeshi, et al.
Publicado: (2021) -
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
por: Ueda, Tatsuki, et al.
Publicado: (2022) -
Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells
por: Ueda, Tatsuki, et al.
Publicado: (2020) -
Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease
por: Iwamoto, Yoshihiro, et al.
Publicado: (2021)